One-of-a-kind diagnostic blood test identifies asymptomatic at-risk patients missed by the current standard of care IRVINE, Calif., June 9, 2021 /PRNewswire/ — Predictive Health Diagnostics Company, Inc. (“PHDC” or “the Company”), a diagnostics development platform company that develops, manufactures, and distributes specialty diagnostic tests combining science, technology, and proprietary analytics to detect diseases with significant unmet medical needs, today announced […]
Other News
Heart & Vascular Center at Valley View Offers Open Heart Surgery and New Cardiothoracic Procedures, Under the Leadership of Cardiothoracic Surgeon Stephen Jones, MD
New Procedures Include Open Heart Surgery, Minimally Invasive Surgical Approaches for Atrial Fibrillation and Heart Valves, and Lung Cancer Operations GLENWOOD SPRINGS, Colo., June 9, 2021 /PRNewswire/ — The Heart & Vascular Center at Valley View is pleased to introduce new services to continue to provide patients with world-class, convenient and compassionate care on […]
InCarda Therapeutics Provides Corporate Update Highlighting New Phase 2 Data for InRhythm™ Program, Plans for Pivotal Phase 3 Study and Expansion of Senior Management Team
Positive Data from Completed InRhythm Phase 2 Study Demonstrate Safe and Rapid Conversions from Atrial Fibrillation to Normal Sinus Rhythm Plans to Initiate RESTORE1: Single Pivotal Phase 3 Trial in Atrial Fibrillation in Q3 2021; Data Expected 2H 2022 Appointment of Angela Wang as CFO Strengthens Management Team and Supports […]
Results From Sequana Medical’s RED DESERT alfapump DSR® Study Selected for Presentation at the Heart Failure 2021 Online Congress
GHENT, Belgium, June 09, 2021 (GLOBE NEWSWIRE) — Sequana Medical NV (Euronext Brussels: SEQUA, the “Company” or “Sequana Medical”), an innovator in the treatment of diuretic-resistant fluid overload in liver disease, malignant ascites and heart failure, today announces that the abstract on the results from its RED DESERT alfapump DSR (Direct Sodium […]
JanOne Advances Toward Initiation of Phase 2b Peripheral Artery Disease (PAD) Trial for Lead Product Candidate JAN101
Successfully Completes Initial Batch Production of JAN101, Demonstrating CGMP-scale Production Capabilities LAS VEGAS, June 8, 2021 /PRNewswire/ — JanOne Inc. (Nasdaq: JAN), a company focused on developing treatments for conditions that cause severe pain and drugs with non-addictive, pain-relieving properties, today announced the successful completion of Current Good Manufacturing Practices (CGMP) production of […]
Sensible Medical and Heart Beat Medical Sign Partnership to Provide UAE with ReDS, Heart Failure Management Solution
ReDS Pulmonary Congestion Monitoring Technology will be Showcased at Upcoming Arab Health Exhibition NETANYA, Israel, June 8, 2021 /PRNewswire/ — Sensible Medical Innovations, the market leader in medical radar monitoring and imaging technology (ReDS™) has signed a partnership with Heart Beat Medical, Dubai, UAE – a leading medical device distributor. This agreement will enable […]
RapidAI Announces New Continuing Education Credits
Leader in Cerebrovascular and Vascular Imaging Expands Clinical Learning and Development Offerings through Rapid U Program SAN MATEO, Calif., June 8, 2021 /PRNewswire/ — RapidAI, the leader in clinical learning and development for stroke, aneurysm, and other cerebrovascular and vascular conditions, today announced the availability of Continuing Education (CE) and Continuing Medical Education […]
Arena Pharmaceuticals Announces First Participant Randomized in Phase 2 Trial Evaluating Temanogrel in Coronary Microvascular Obstruction (cMVO)
– Evaluating the safety, tolerability, and efficacy of intravenous (IV) temanogrel for cMVO in adult participants undergoing percutaneous coronary intervention (PCI) – Currently no FDA approved therapies indicated for the treatment of cMVO – Temanogrel was granted FDA Fast Track Designation for the treatment of cMVO PARK CITY, Utah–(BUSINESS WIRE)–Arena […]
Baxter Presents Data at 58th ERA-EDTA Congress Indicating Theranova May Reduce Cardiovascular Events and Hospitalizations
Large, multicenter, retrospective study of Colombian dialysis patients indicates cardiovascular events were 35% lower for patients on HDx therapy enabled by Theranova than participants on standard hemodialysis1 Data from study also show HDx therapy may reduce hospitalization rates up to 18%1 DEERFIELD, Ill.–(BUSINESS WIRE)–Baxter International Inc. (NYSE:BAX), a global innovator in renal care, announced […]
Medtronic Insertable Cardiac Monitor Detects Significantly Higher Rates of Atrial Fibrillation in Large and Small Vessel Stroke Patients Compared to Standard of Care
Publication in JAMA Shows Reveal LINQ™ ICM Demonstrated a Seven-Fold Increase in Detecting AF vs. Standard of Care DUBLIN, June 7, 2021 /PRNewswire/ — Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced clinical trial results from the STROKE AF trial demonstrating the superiority of the Reveal LINQ™ Insertable Cardiac Monitor […]



